Literature DB >> 6736144

Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides.

J Rivier, R McClintock, R Galyean, H Anderson.   

Abstract

Biologically active peptides synthesized by the solid phase methodology of Merrifield were purified by reversed-phase high-performance liquid chromatography using newly developed preparative radially compressed cartridges fitting Waters Assoc . Prep LC 500 liquid chromatograph. Cartridges were handpacked with Vydac C18, C4 or diphenyl derivatized silicas (pore size 300 A) of different particle sizes (10-20 micron). Large scale purification of gram amounts of gonadotropin releasing hormone analogs (agonist and antagonist) as well as amidated human pancreatic tumor growth hormone releasing factor (a 40-peptide) illustrate the resolutive power of this technique applied to the isolation of more than 300 synthetic peptides in our laboratory over the last two years. Difficult separations were achieved by changing supports (C18, C4, diphenyl) as well as mobile phase composition: (triethylammonium phosphate pH 2.25 or 6.5, 0.1% trifluoroacetic acid, ammonium acetate pH 6.5 and acetonitrile). Protected amino acids and peptides amenable to normal-phase chromatography on Vydac spherical underivatized silica were purified economically by the reversed-phase mode. It is understood that this general, convenient and versatile strategy may be applicable to the preparative scale isolation of any other class of compounds usually separated on reversed-phase high-performance liquid chromatography.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6736144     DOI: 10.1016/s0021-9673(01)93709-4

Source DB:  PubMed          Journal:  J Chromatogr


  16 in total

1.  Mass-based fraction collection of crude synthetic peptides in analytical and preparative scale.

Authors:  Ralf Moritz; Nicola O'Reilly
Journal:  J Biomol Tech       Date:  2003-06

2.  Preparative reversed-phase high-performance liquid chromatography collection efficiency for an antimicrobial peptide on columns of varying diameters (1mm to 9.4mm I.D.).

Authors:  Yuxin Chen; Colin T Mant; Robert S Hodges
Journal:  J Chromatogr A       Date:  2006-12-06       Impact factor: 4.759

3.  In-process controls and characterization of recombinate antihemophilic factor (recombinant).

Authors:  M Griffith; H Kingdon; S L Liu; W Burkart
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

4.  Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli.

Authors:  M G Cordingley; R B Register; P L Callahan; V M Garsky; R J Colonno
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Purification and characterization of peptides with corticotropin-releasing factor activity from porcine hypothalami.

Authors:  M Patthy; D H Schlesinger; J Horvath; M Mason-Garcia; B Szoke; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Influence of protein flexibility and peptide conformation on reactivity of monoclonal anti-peptide antibodies with a protein alpha-helix.

Authors:  T M Fieser; J A Tainer; H M Geysen; R A Houghten; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Isolation and amino acid sequence of corticotropin-releasing factor from pig hypothalami.

Authors:  M Patthy; J Horvath; M Mason-Garcia; B Szoke; D H Schlesinger; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Process for production and purification of Lethal Toxin Neutralizing Factor (LTNF) from E. coli and its economic analysis.

Authors:  Vishwanath Hebbi; P Kathiresan; Devendra Kumar; Claire Komives; Anurag S Rathore
Journal:  J Chem Technol Biotechnol       Date:  2017-12-05       Impact factor: 3.174

9.  Two new forms of gonadotropin-releasing hormone in a protochordate and the evolutionary implications.

Authors:  J F Powell; S M Reska-Skinner; M O Prakash; W H Fischer; M Park; J E Rivier; A G Craig; G O Mackie; N M Sherwood
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Three forms of gonadotropin-releasing hormone characterized from brains of one species.

Authors:  J F Powell; Y Zohar; A Elizur; M Park; W H Fischer; A G Craig; J E Rivier; D A Lovejoy; N M Sherwood
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.